All Stocks

AMAT

Boston Scientific Corp

$353.80

Closing price as of Apr 1, 2026

23 superinvestors own AMAT

Based on latest 13F filings — data is 45–90 days delayed

View consensus →
InvestorWeightActivity
David Tepper5.44%Added
John Armitage3.92%Reduced
William Von Mueffling3.46%Reduced
Lee Ainslie3.43%Reduced
Chase Coleman2.48%Added
Harry Burn2.29%Reduced
Christopher Davis1.88%Reduced
David Katz1.84%Reduced
David Einhorn1.22%Reduced
Third Avenue Management0.74%Reduced
Chris Hohn0.55%New
First Eagle Investment Management0.22%Added
Kenneth Fisher0.05%Reduced
Torray Funds0.04%New
Mairs & Power0.04%Held
Meridian / ArrowMark0.04%Reduced
Bill & Melinda Gates Foundation0.01%New
Glenn Greenberg0.01%Held
Richard Pzena0.00%New
Dodge & Cox0.00%Reduced
Jensen Investment Management0.00%Reduced
Ruane Cunniff0.00%Held
Bill Nygren0.00%Held

Recent insider activity — AMAT

Open-market purchases (P) and sales (S) from SEC Form 4 filings · last 12 months

No open-market insider trades in the last 12 months.

Form 4 filings for option exercises and other transaction types are excluded.

Congressional trades — AMAT

STOCK Act disclosures · last 12 months

Congressional trade data coming soon.

We are sourcing STOCK Act disclosures and will display them here shortly.

Learn more